Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.
about
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersBrain endothelial cell-cell junctions: how to "open" the blood brain barrierHow hyperglycemia promotes atherosclerosis: molecular mechanisms.Vascular endothelial dysfunction and pharmacological treatmentPeripheral effect of alpha-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscleAryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cellsInvolvement of protein kinase C beta 2 in c-myc induction by high glucose in pancreatic beta-cellsRenal and systemic effects of endothelin-1 in diabetic-hypertensive rats.Regulation of the ligand binding activity of the human very low density lipoprotein receptor by protein kinase C-dependent phosphorylation.Current and future pharmacological intervention for diabetic retinopathy.Diabetic retinopathy: current management and experimental therapeutic targets.Molecular mechanisms of diabetic vascular complicationsActivation of protein kinase C isoforms and its impact on diabetic complications.Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic ratsIL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation.Decreased contractile response to endothelin-1 of peripheral microvasculature from diabetic patients.Spironolactone rescues Dot1a-Af9-mediated repression of endothelin-1 and improves kidney injury in streptozotocin-induced diabetic ratsProtein kinase C and the development of diabetic vascular complications.Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation.Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF.Ameliorative effect of allopurinol on vascular complications of insulin resistanceDiabetes mellitus and heart failure.Endothelins in chronic diabetic complications.Diabetic retinopathy, superoxide damage and antioxidants.Effects of Epigallocatechin-3-Gallate on the Expression of TGF-β1, PKC α/βII, and NF-κB in High-Glucose-Stimulated Glomerular Epithelial Cells.Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling.Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational researchHyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.Endothelin receptor-A antagonist attenuates retinal vascular and neuroretinal pathology in diabetic mice.Experimental mechanisms of diabetic embryopathy and strategies for developing therapeutic interventions.The vascular endothelium in diabetes--a therapeutic target?Role of raf-1 kinase in diabetes-induced accelerated apoptosis of retinal capillary cells.The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy.Insulin decreases atherosclerosis by inducing endothelin receptor B expression.Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.PKCδ impaired vessel formation and angiogenic factor expression in diabetic ischemic limbs.Cellular signaling and potential new treatment targets in diabetic retinopathy.Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosisProtein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications.Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium.
P2860
Q24644869-9A303183-4E32-4496-80C3-7BBC805FBEEBQ24654117-8EAAE634-6360-46FC-A62A-341B567D9BEDQ24795988-FB36B8AE-AB5D-4F2F-8CCE-4304F5001DC6Q26774561-378ECCDA-10B4-4C49-88B6-7525C82D13ADQ28275704-8EC79970-21A6-4E4A-8B4A-2AD229938F87Q28390982-E4D99031-CECA-4563-87E9-4EB62F4F7BA3Q28566691-78ACC033-539A-4503-89A1-0E061B1AAA93Q31031204-470A6121-DEB8-430F-9550-7A3D65D2B89DQ31442067-195C91A4-B2FF-4B62-810F-6BA46D262448Q33216425-8C7702B0-3A2E-4F49-9EEA-D6E704DC6BEEQ33403016-453DB34A-4E88-4FA5-A064-CE91ACF197B6Q33558421-7217FC3D-E9C1-43B9-BBB5-EF07B2199710Q33881442-774A5955-E766-42F7-9D1B-4DB2A36B2367Q34067524-0F2E8863-AE46-4126-A5DD-447A3BEC9B2FQ34277556-60E03A67-1DB8-4CA6-A596-B73C9F52BE5AQ34400392-F2F7A452-E9E9-444A-989B-9776B8206953Q34450762-96C4A40E-5EB7-4CF2-A383-75B29D01D22DQ34570516-8E2FABD7-92E0-425C-BAE0-D47F6F1D381DQ34620459-6EBE6113-5242-4627-8F83-8B688C145832Q34733351-E1A79A77-03E1-4927-891A-86391733D953Q35133164-844EED90-40AB-4A71-B549-43D01B3B8DE4Q35162693-18B3A005-D2B7-441D-BBCD-B80AC8F252EEQ35168430-7AA860B6-69CE-467D-AF93-12BC7D323FE0Q35545811-8076B626-3F1B-46A5-B4CE-57B8F203C91AQ35546208-17439C30-A127-455C-84B3-8EC3F65D63B3Q35561699-7DC06C34-B398-43DC-AD69-49E9D021BE04Q35615435-B94F95A7-FD0A-4583-BBEA-45B441A50911Q35830289-7DB8836D-BDC8-45E2-A78A-94C9673E1949Q36098922-929AC6D3-7FAF-4E82-9659-735582BDF91AQ36330216-3CFFC48D-42BA-4595-8837-94A038222E9AQ36673550-4E7F7578-BA43-4D4B-8B30-7071FB607ADFQ36735369-A389D5A7-EB88-4884-AB47-EB2622558C8FQ36904452-04873198-0A79-4778-A3DB-57072BBBC5CDQ36908280-5D307769-BA72-4312-AB0C-36CD0ECA80DCQ36966060-8E2EBE2E-969C-4529-A07C-22CA522C4B35Q37031000-647F3E2A-0F84-4ED7-8D61-EE3AFB3A62F9Q37089750-880DB7CB-0D71-4A5E-98A8-54AB12989371Q37139800-E7F34B20-8DFA-4E62-8B5C-619D1D340B8CQ37165694-6C04944A-5E51-4D6F-B0A8-731B0AEB8D35Q37486289-AB0264EF-1463-44F8-919B-FFDFF99C0847
P2860
Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Induction of endothelin-1 expr ...... f protein kinase C activation.
@en
Induction of endothelin-1 expr ...... f protein kinase C activation.
@nl
type
label
Induction of endothelin-1 expr ...... f protein kinase C activation.
@en
Induction of endothelin-1 expr ...... f protein kinase C activation.
@nl
prefLabel
Induction of endothelin-1 expr ...... f protein kinase C activation.
@en
Induction of endothelin-1 expr ...... f protein kinase C activation.
@nl
P2093
P1433
P1476
Induction of endothelin-1 expr ...... f protein kinase C activation.
@en
P2093
A Gabriele
C J Rhodes
N Takahara
P304
P356
10.2337/DIABETES.49.7.1239
P407
P577
2000-07-01T00:00:00Z